Optimum Investment Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Optimum Investment Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100	Closed	-$18K	–	946
2021 Q2	$18K	Hold	100	–	–	0.01%	677
2021 Q1	$15K	Hold	100	–	–	﹤0.01%	719
2020 Q4	$16K	Hold	100	–	–	﹤0.01%	664
2020 Q3	$11K	Hold	100	–	–	﹤0.01%	696
2020 Q2	$11K	Hold	100	–	–	﹤0.01%	691
2020 Q1	$9K	Hold	100	–	–	﹤0.01%	705
2019 Q4	$11K	Hold	100	–	–	﹤0.01%	768
2019 Q3	$10K	Hold	100	–	–	﹤0.01%	808
2019 Q2	$13K	Hold	100	–	–	﹤0.01%	743
2019 Q1	$14K	Hold	100	–	–	﹤0.01%	756
2018 Q4	$10K	Hold	100	–	–	﹤0.01%	766
2018 Q3	$14K	Hold	100	–	–	﹤0.01%	801
2018 Q2	$12K	Hold	100	–	–	﹤0.01%	824
2018 Q1	$11K	Buy	+100	New	+$12K	﹤0.01%	816
2015 Q1	$17K	Hold	100	–	–	0.01%	727
2014 Q4	$19K	Hold	100	–	–	0.01%	738
2014 Q3	$17K	Hold	100	–	–	0.01%	681
2014 Q2	$16K	Hold	100	–	–	0.01%	703
2014 Q1	$15K	Hold	100	–	–	0.01%	553
2013 Q4	$13K	Hold	100	–	–	﹤0.01%	580
2013 Q3	$12K	Buy	+100	New	+$11K	﹤0.01%	564

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Optimum Investment Advisors's ALXN Position: Q3 2021 in Review

Optimum Investment Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 100 shares — an estimated $18K sold.

Optimum Investment Advisors first reported a position in ALXN in Q3 2013 and held it in 21 quarters. The position peaked at $19K in Q4 2014. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Optimum Investment Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Optimum Investment Advisors sold 100 Alexion Pharmaceuticals shares in Q3 2021, an estimated $18K.
Optimum Investment Advisors first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 21 quarters.
Optimum Investment Advisors's Alexion Pharmaceuticals position peaked at $19K in Q4 2014.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Optimum Investment Advisors's 13F filing for Q3 2021, filed 12 Oct 2021.